from The American Heritage® Dictionary of the English Language, 4th Edition

  • abbr. luteinizing hormone-releasing hormone

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • Luteinizing Hormone-Releasing Hormone


Sorry, no etymologies found.


  • Drugs in this category include danazol (Danocrine), leuprolide acetate (the same medicines used to treat endometriosis), and a promising new treatment called LHRH.

    Getting Pregnant

  • Short secreted peptides were known to function as hormones, circulating throughout the bloodstream and affecting multiple target organs, but the Jans provided the first definitive evidence that a peptide known as LHRH could also be released by nerve terminals in response to neural activity and could regulate the electrical activity of other nearby neurons.

    Newswise: Latest News

  • For example, a comparison of amino acid sequences of luteinizing hormone-releasing hormone (LHRH) from several species showed (on the evolutionary view) that amphibians and mammals are more closely related than reptiles and mammals (King and Millar 1979).

    Experts in creationism trials -- Shallit be? - The Panda's Thumb

  • Various injectable depot formulations including long-acting solid injectable implants for LHRH-agonist and microsphere formulations for several therapeutic proteins are currently under development. Press Releases

  • It will include up to 64 patients, both male and female, with advanced LHRH-receptor positive urothelial (bladder) cancer.

    The Globe and Mail - Home RSS feed

  • He identified and led the development of Zoladex®, the LHRH agonist for the first line treatment of advanced prostate cancer.

    GTx Appoints Dr. Barry Furr to the Board of Directors - Yahoo! Finance

  • Watson also has submitted a New Drug Application for a 6-month formulation of Trelstar (R) (triptorelin pamoate), a luteinizing hormone releasing hormone (LHRH) agonist for the palliative treatment of advanced prostate cancer.

    Medlogs - Recent stories

  • Clinical data and the opinions of interviewed thought leaders indicate that Sanofi-Aventis's Taxotere has advantages in this attribute over LHRH agonists, including Abbott's Lupron Depot, the sales-leading agent in the market.

    Random feeds from

  • The patients were randomized 1: 2 to an LHRH analog or to transdermal patches that released - medical news plus CME for physicians

  • By week 12, 26 of 28 evaluable patients (92. 8\%) assigned to the LHRH analog had castrate levels of testosterone, and none had levels between 50 and 100 ng / dL. - medical news plus CME for physicians


Log in or sign up to get involved in the conversation. It's quick and easy.